Naviter Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Sell
945
-350
-27% -$115K 0.03% 241
2025
Q4
$454K Sell
1,295
-240
-16% -$81.1K 0.06% 206
2025
Q3
$496K Sell
1,535
-436
-22% -$136K 0.06% 202
2025
Q2
$767K Sell
1,971
-360
-15% -$145K 0.09% 176
2025
Q1
$1.01M Sell
2,331
-1,193
-34% -$479K 0.12% 172
2024
Q4
$1.3M Buy
+3,524
New +$1.47M 0.16% 151
2024
Q1
Sell
-1,808
Closed -$853K 238
2023
Q4
$853K Buy
1,808
+390
+28% +$180K 0.17% 149
2023
Q3
$617K Buy
1,418
+100
+8% +$45.4K 0.15% 159
2023
Q2
$586K Buy
1,318
+139
+12% +$64.1K 0.15% 166
2023
Q1
$542K Buy
+1,179
New +$561K 0.19% 144

Other funds holding ELV

Naviter Wealth's ELV Position: Q1 2026 in Review

Naviter Wealth reduced its Elevance Health (ELV) stake by 27% in Q1 2026, selling an estimated $115K and leaving 945 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #241.

Naviter Wealth first reported a position in ELV in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.3M in Q4 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Naviter Wealth held 945 shares of Elevance Health worth $277K as of Q1 2026.
  • Naviter Wealth sold 350 Elevance Health shares in Q1 2026, an estimated $115K.
  • Elevance Health made up 0.03% of Naviter Wealth's portfolio in Q1 2026, its #241 holding.
  • Naviter Wealth first reported a position in Elevance Health in Q1 2023 and has held it in 10 quarters since.
  • Naviter Wealth's Elevance Health position peaked at $1.3M in Q4 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.